Osaic Holdings’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $205K | Buy |
21,539
+251
| +1% | +$2.39K | ﹤0.01% | 3586 |
|
|
2025
Q1 | $103K | Sell |
21,288
-5,172
| -20% | -$25.1K | ﹤0.01% | 4129 |
|
|
2024
Q4 | $253K | Buy |
26,460
+10,188
| +63% | +$97.4K | ﹤0.01% | 3393 |
|
|
2024
Q3 | $136K | Sell |
16,272
-734
| -4% | -$6.13K | ﹤0.01% | 3970 |
|
|
2024
Q2 | $116K | Buy |
17,006
+7,066
| +71% | +$48.2K | ﹤0.01% | 4005 |
|
|
2024
Q1 | $25.1K | Buy |
9,940
+1,990
| +25% | +$5.03K | ﹤0.01% | 5183 |
|
|
2023
Q4 | $19.1K | Sell |
7,950
-916
| -10% | -$2.2K | ﹤0.01% | 5500 |
|
|
2023
Q3 | $30.1K | Buy |
8,866
+3,199
| +56% | +$10.9K | ﹤0.01% | 5309 |
|
|
2023
Q2 | $41.6K | Buy |
5,667
+3,301
| +140% | +$24.2K | ﹤0.01% | 5052 |
|
|
2023
Q1 | $24.8K | Sell |
2,366
-989
| -29% | -$10.4K | ﹤0.01% | 5425 |
|
|
2022
Q4 | $39.5K | Sell |
3,355
-810
| -19% | -$9.53K | ﹤0.01% | 5095 |
|
|
2022
Q3 | $87K | Sell |
4,165
-6,158
| -60% | -$129K | ﹤0.01% | 4482 |
|
|
2022
Q2 | $321K | Sell |
10,323
-635
| -6% | -$19.7K | ﹤0.01% | 3364 |
|
|
2022
Q1 | $445K | Sell |
10,958
-162
| -1% | -$6.58K | ﹤0.01% | 3329 |
|
|
2021
Q4 | $485K | Sell |
11,120
-90
| -0.8% | -$3.93K | ﹤0.01% | 3095 |
|
|
2021
Q3 | $563K | Sell |
11,210
-6,784
| -38% | -$341K | ﹤0.01% | 2911 |
|
|
2021
Q2 | $1.14M | Buy |
17,994
+6,488
| +56% | +$409K | ﹤0.01% | 2241 |
|
|
2021
Q1 | $1.06M | Sell |
11,506
-704
| -6% | -$64.9K | ﹤0.01% | 2178 |
|
|
2020
Q4 | $1.1M | Sell |
12,210
-4,977
| -29% | -$446K | ﹤0.01% | 1942 |
|
|
2020
Q3 | $1.77M | Sell |
17,187
-1,482
| -8% | -$153K | 0.01% | 1386 |
|
|
2020
Q2 | $1.48M | Buy |
18,669
+4,495
| +32% | +$356K | 0.01% | 1455 |
|
|
2020
Q1 | $820K | Buy |
+14,174
| New | +$820K | ﹤0.01% | 1684 |
|